Abstract

BackgroundReports on the antischistosomal effect of several antimalarial drugs such as artesunate, mefloquine, and amodiaquine suggest that febrifugine, which exerts an antimalarial effect, can also be expected to possess antischistosomal potential. The present study investigates the antischistosomal effects of febrifugine.MethodsIn experiment 1, Schistosoma mansoni adult worm pairs were incubated in a medium alone as a control or supplemented with febrifugine at 0.05, 0.1, 0.2, and 0.5 μg/ml for 14 days. The morphology of the worms and the egg production of the female worms were observed simultaneously. In experiment 2, the incubation was conducted as in experiment 1, except that the febrifugine concentrations were reduced to 0.005, 0.01, and 0.02 μg/ml. In addition, S. mansoni adult worms were incubated with either 0.5 μg/ml febrifugine or none as a control for 5 days and stained with neutral red dye.ResultsFebrifugine significantly reduced the survival of S. mansoni male and female worms at concentrations of 0.02–0.5 μg/ml following incubation for 14 days and remarkably inhibited the daily egg output of the female worms. The non-treated male and female worms remained morphologically normal within the period of 14 days, whereas male and female worms treated with febrifugine at different concentrations gradually twisted and subsequently died. In addition, S. mansoni adult worms were incubated with either 0.5 μg/ml febrifugine or none as a control for 5 days and stained with neutral red dye. Non-treated male worms were morphologically normal and stained dark red with neutral red, while febrifugine-treated male worms appeared similar to those in the control group and were stained at a slightly lower level of dark red than the non-treated male worms. Non-treated female worms were morphologically normal, and their intestinal tract and vitellaria were stained deep red and dark red, respectively. In contrast, febrifugine-treated female worms were morphologically damaged, and their intestinal tract and vitellaria remained mostly unstained and stained dark red, respectively.ConclusionFebrifugine exerts potent antischistosomal effects and can be expected to contribute to the development of a novel antischistosomal drug.

Highlights

  • Reports on the antischistosomal effect of several antimalarial drugs such as artesunate, mefloquine, and amodiaquine suggest that febrifugine, which exerts an antimalarial effect, can be expected to possess antischistosomal potential

  • Feb was on the verge of serving as a potent new antimalarial drug, but its severe side effects precluded its use as a clinical antimalarial drug for half a century [13, 15]

  • In the present groundbreaking study, we evaluated the in vitro antischistosomal effects of Feb according to the modified method of Mitsui et al (2009) [6]

Read more

Summary

Introduction

Reports on the antischistosomal effect of several antimalarial drugs such as artesunate, mefloquine, and amodiaquine suggest that febrifugine, which exerts an antimalarial effect, can be expected to possess antischistosomal potential. Some 61 million people were treated with praziquantel (PZQ) by 2014, but an estimated 260 million people continue to require treatment Artemisinin derivatives such as artemether and artesunate (ART) are well-known antimalarial drugs that exert an antischistosomal effect [5, 6]. Other antimalarial drugs in current use, such as mefloquine (MQ), Mitsui et al Tropical Medicine and Health (2020) 48:42 amodiaquine (AQ), and primaquine (PQ), display antischistosomal effects [7, 8], further suggesting that compounds possessing antimalarial activity may display antischistosomal potential. The assessment of the antischistosomal effects of Feb, constitutes a new approach to the development of a novel antischistosomal drug

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call